These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38498979)

  • 21. Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence.
    Avagliano C; Russo R; De Caro C; Cristiano C; La Rana G; Piegari G; Paciello O; Citraro R; Russo E; De Sarro G; Meli R; Mattace Raso G; Calignano A
    Pharmacol Res; 2016 Nov; 113(Pt A):276-289. PubMed ID: 27616549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative Characterization of Phenotypical Markers After Differentiation of SH-SY5Y Cells.
    Ducray AD; Wiedmer L; Herren F; Widmer HR; Mevissen M
    CNS Neurol Disord Drug Targets; 2020; 19(8):618-629. PubMed ID: 32640966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppressing nNOS Enzyme by Small-Interfering RNAs Protects SH-SY5Y Cells and Nigral Dopaminergic Neurons from 6-OHDA Injury.
    Titze-de-Almeida R; Titze-de-Almeida SS; Ferreira NR; Fontanari C; Faccioli LH; Del Bel E
    Neurotox Res; 2019 Jul; 36(1):117-131. PubMed ID: 31041676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
    Kopalli SR; Noh SJ; Koppula S; Suh YH
    Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of latroeggtoxin-VI on dopamine and α-synuclein in PC12 cells and the implications for Parkinson's disease.
    Yu D; Wang H; Zhai Y; Lei Z; Sun M; Chen S; Yin P; Wang X
    Biol Res; 2024 Mar; 57(1):9. PubMed ID: 38491377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels.
    Vergo S; Johansen JL; Leist M; Lotharius J
    Brain Res; 2007 Dec; 1185():18-32. PubMed ID: 18028884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of hydralazine on a cellular model of Parkinson's disease: a possible role of hypoxia-inducible factor (HIF)-1α.
    Mehrabani M; Nematollahi MH; Tarzi ME; Juybari KB; Abolhassani M; Sharifi AM; Paseban H; Saravani M; Mirzamohammadi S
    Biochem Cell Biol; 2020 Jun; 98(3):405-414. PubMed ID: 31940231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
    Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
    Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotection of inositol hexaphosphate and changes of mitochondrion mediated apoptotic pathway and α-synuclein aggregation in 6-OHDA induced parkinson's disease cell model.
    Zhang Z; Hou L; Li X; Ju C; Zhang J; Li X; Wang X; Liu C; Lv Y; Wang Y
    Brain Res; 2016 Feb; 1633():87-95. PubMed ID: 26740400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2.
    Jing X; Wei X; Ren M; Wang L; Zhang X; Lou H
    Neurochem Res; 2016 Apr; 41(4):779-86. PubMed ID: 26537816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycyrrhizic Acid Alleviates 6-Hydroxydopamine and Corticosterone-Induced Neurotoxicity in SH-SY5Y Cells Through Modulating Autophagy.
    Yang G; Li J; Cai Y; Yang Z; Li R; Fu W
    Neurochem Res; 2018 Oct; 43(10):1914-1926. PubMed ID: 30206804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway.
    Zhang XS; Ha S; Wang XL; Shi YL; Duan SS; Li ZA
    Neuroscience; 2015 Sep; 303():489-502. PubMed ID: 26116522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats.
    Inden M; Kitamura Y; Kondo J; Hayashi K; Yanagida T; Takata K; Tsuchiya D; Yanagisawa D; Nishimura K; Taniguchi T; Shimohama S; Sugimoto H; Akaike A
    J Neurochem; 2005 Nov; 95(4):950-61. PubMed ID: 16135081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin I mediates neuroprotective effect through attenuation of quinoprotein formation, p-p38 MAPK expression, and caspase-3 activation in 6-hydroxydopamine treated SH-SY5Y cells.
    Meesarapee B; Thampithak A; Jaisin Y; Sanvarinda P; Suksamrarn A; Tuchinda P; Morales NP; Sanvarinda Y
    Phytother Res; 2014 Apr; 28(4):611-6. PubMed ID: 23857913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein.
    Park SS; Schulz EM; Lee D
    Eur J Neurosci; 2007 Dec; 26(11):3104-12. PubMed ID: 18005066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists.
    Presgraves SP; Ahmed T; Borwege S; Joyce JN
    Neurotox Res; 2004; 5(8):579-98. PubMed ID: 15111235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.
    Nouraei N; Zarger L; Weilnau JN; Han J; Mason DM; Leak RK
    Toxicol Appl Pharmacol; 2016 Apr; 296():19-30. PubMed ID: 26879220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citronellol Prevents 6-OHDA-Induced Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Parkinson Disease Model of SH-SY5Y Cells via Modulating ROS-NO, MAPK/ERK, and PI3K/Akt Signaling Pathways.
    Shao J; Liu X; Lian M; Mao Y
    Neurotox Res; 2022 Dec; 40(6):2221-2237. PubMed ID: 36097250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.